[Side-effects in cytostatic drug therapy].
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000188:drug therapy; D002273:Carcinogens / Q000494:pharmacology; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000139:chemically induced / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy; D014228:Triaziquone / Q000009:adverse effects
D000970:Antineoplastic Agents; D002273:Carcinogens; D003520:Cyclophosphamide; D014228:Triaziquone
Nebenwirkungen der Therapie mit cytostatischen Arzneimitteln.